Annotated Medicine and Device Lists

Artesunate

This medicine is present in:

List Section Observation
Barbados. Barbados National Drug Formulary (BNDF) 08.30 Antiprotozoals No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.5.3.1. For curative treatment Others observations:
To be used in combination with either amodiaquine, mefloquine or sulfadoxine + pyrimethamine.
PAHO Strategic Fund Medicine List 2.7.2. Anti-malarial No observations
Suriname. NGK-C-011 6.10 Anti-Protozoan Agents: Anti-Malaria Agents No observations

This medicine is present in:

List Section Observation
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 P. PRODUTOS ANTIPARASITARIOS, INSECTICIDAS E REPELENTES No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.5.3.1. For curative treatment This medicine is only for children.
Others observations:
To be used in combination with either amodiaquine, mefloquine or sulfadoxine + pyrimethamine. For pre-referral treatment of severe malaria only; patients should be taken to an appropriate health facility for follow-up care.

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.5.3.1. For curative treatment This medicine is only for children.
Others observations:
To be used in combination with either amodiaquine, mefloquine or sulfadoxine + pyrimethamine. For pre-referral treatment of severe malaria only; patients should be taken to an appropriate health facility for follow-up care.
PAHO Strategic Fund Medicine List 2.7.2. Anti-malarial Others observations:
Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.5.3.1. For curative treatment This medicine requires a children care specialist.

This medicine is present in:

List Section Observation
Peru 6.5.3 Antimalarials No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.5.3.1. For curative treatment Others observations:
To be used in combination with either amodiaquine, mefloquine or sulfadoxine + pyrimethamine.
PAHO Strategic Fund Medicine List 2.7.2. Anti-malarial No observations
Peru 6.5.3 Antimalarials No observations
Paraguay. Lista de Medicamentos Esenciales. 2009 01. ANTIPROTOZOARIOS No observations
Barbados. Barbados National Drug Formulary (BNDF) 08.30 Antiprotozoals No observations

This medicine is present in:

List Section Observation
Suriname. NGK-C-011 6.10 Anti-Protozoan Agents: Anti-Malaria Agents No observations

This medicine is present in:

List Section Observation
Guyana. Essential Medicines List. 2020-2021 Reserve second-line medicines used to treat Malaria No observations

This medicine is present in:

List Section Observation
Peru 6.5.3 Antimalarials No observations

Information Resources: Artesunate

No information available